Startups vs COVID-19

A repository of resources for Indian startups solving challenges created by COVID-19

California Institute for Regenerative Medicine

Ticket Size
$5 million

CIRM mission is to accelerate stem cell treatments to patients with unmet medical needs. California researchers have made us aware that they are pursuing potential stem cell based approaches to the COVID-19 crisis. The Board’s decision enables CIRM to allocate $5 million in funding for peer-reviewed regenerative medicine and stem cell research that could quickly advance treatments for COVID-19.

Deadline to Apply

Help the community by contributing to this platform 💜

This platform is built & maintained by a bunch of startup enthusiasts. We are constantly updating the repository with resources for startups sourced from the public, private, and non-governmental sectors.

Interested in contributing to the repository?